UPL (UPL) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
2 Feb, 2026Executive summary
Achieved record Q3 and nine-month results, with 12% YoY Q3 revenue growth and broad-based EBITDA growth, reflecting disciplined execution and resilient business strategy.
Operational PATMI rose 45% YoY in Q3, with significant improvement in PBT (+90%) and EBITDA (+13%).
Maintained strong operational momentum despite geopolitical, pricing, and trade headwinds in the crop production value chain.
Filed DRHP for Advanta seeds business IPO, marking a step toward potential restructuring and value unlocking.
Received top ESG ratings and governance awards, reinforcing sustainability and transparency focus.
Financial highlights
Q3 FY26 revenue reached ₹12,269 crore, up 12% YoY; nine-month revenue was ₹33,504 crore, up 8% YoY.
Q3 EBITDA grew 13% YoY to ₹2,434 crore; nine-month EBITDA up 22% to ₹5,941 crore.
Q3 PBT surged 90% YoY to ₹671 crore; operational PATMI rose 45% YoY to ₹452 crore, adjusted for exceptional items.
Net working capital at 116 days, up nine days YoY, reflecting higher inventory and receivables in anticipation of Q4 sales.
Net debt as of Dec 31, 2025, stood at ₹23,317 crore ($2.594 billion), down over ₹2,500 crore YoY, with improved gearing ratios.
Outlook and guidance
Confident in achieving full-year FY26 guidance of 4%-8% revenue growth and 12%-16% EBITDA growth.
Expect strong Q4 across all regions, with volume-led growth and continued operational focus.
New product launches expected to exceed $130 million in revenue for the year, supporting future growth.
Crop protection, Advanta, and SUPERFORM forecasted to deliver strong growth and margin expansion.
Latest events from UPL
- Reorganization creates a focused, listed crop protection leader with enhanced value and efficiency.UPL
Investor presentation20 Feb 2026 - Q2 FY2025 saw strong volume growth and lower net debt, but margins declined on pricing pressure.UPL
Q2 24/253 Feb 2026 - Q1 FY25 saw a net loss of ₹965 crore on ₹9,067 crore revenue, with margin recovery expected.UPL
Q1 24/252 Feb 2026 - Q3 FY25 saw strong profit recovery, margin expansion, and significant debt reduction.UPL
Q3 24/259 Jan 2026 - Record FY25 profit, EBITDA growth, and deleveraging set stage for continued margin expansion.UPL
Q4 & Investor Day 24/2520 Nov 2025 - Q2 FY26 delivered strong revenue growth, profit recovery, and upgraded EBITDA guidance.UPL
Q2 20268 Nov 2025 - Double-digit EBITDA growth and margin expansion achieved despite a quarterly net loss.UPL
Q1 25/262 Aug 2025